Cornell researchers develop reversible, nonhormonal male contraceptive in mice
📰 Original title: Scientists discover reversible male birth control that stops sperm production
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅
View full AI summary: https://killbait.com/en/cornell-researchers-develop-reversible-nonhormonal-male-contraceptive-in-mice/?redirpost=99d64db4-7d7a-4fc8-94dc-dad2a0bbd5ff
Cornell researchers develop reversible, nonhormonal male contraceptive in mice
📰 Original title: Scientists discover reversible male birth control that stops sperm production
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅
View full AI summary: https://killbait.com/en/cornell-researchers-develop-reversible-nonhormonal-male-contraceptive-in-mice/?redirpost=99d64db4-7d7a-4fc8-94dc-dad2a0bbd5ff
#Vasektomie seit 2004 keine #Kassenleistung mehr 👎 & sowas schimpft sich #Gesundheitsreform. Merci für nichts
> Laut einem Vorschlag vom #Gesundheitsministerium (#BMG) soll’s ab 2026 200 Euro Zuschuss geben, wenn du über 35 bist und mindestens 2 Kinder hast. Zusätzlich soll es Aufklärungspflicht geben, damit du vorher weißt, was Sache ist.
Jedoch keine Idee, warum das an irgendein Alter UND irgendwelche Kinderzahlen geknüpft sein soll 😡 Bullshit
Vasectomies: An option for male contraception. 🩺 In this article, Tshepy Matloga-Malope explains the simple procedure that helps men who’ve decided to not have more children. Learn more about male sterilisation at BabyYumYum: https://zurl.co/FGuS
#Vasectomy #MaleContraception #FamilyPlanning #PermanentContraception #BYY
Contraception for men is becoming a reality. The article is in French.
Alors que la contraception est légalisée au Canada depuis 55 ans, la plupart des moyens de contrôle des naissances demeurent, encore aujourd’hui, destinés aux femmes. Or, de plus en plus de gens souhaitent voir émerger de nouvelles méthodes de contraception masculine.
On Jan 4th results from #Contraline's successful first-in-human early-stage trial dropped in and demonstrated reversibility. This is another really important milestone in reaching #reproductiveAutonomyForAll
https://www.wired.com/story/male-contraceptive-contraline-vasalgel-hydrogel/
#vasDeferens #vasalgel #maleContraception
#nextLifeSciences #ParsemusFoundation #MaleContraceptiveInitiative
a 2023 comprehensive overview on the development of hormonal and non-hormonal approaches to reversible #MaleContraception
> It is long overdue that male partners share the burden of #familyPlanning, and it is the authors’ hope that this will soon be a possibility.
https://bacandrology.biomedcentral.com/articles/10.1186/s12610-023-00204-z
#vasDeferens #vasalgel #nestorone #eppin #SLO3 #sACInhibition #ADAM #contralineInc #RISUG
Background Since the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied. The purpose of this narrative review is to provide clinicians and laypeople with focused, up-to-date descriptions of novel strategies and targets for male contraception. We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development. Results As of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy. A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024. A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024. There are also several non-hormonal methods with strong potential in preclinical stages of development. Conclusions There exist several hurdles to novel male contraception. Therapeutic development takes decades of time, meticulous work, and financial investment, but with so many strong candidates it is our hope that there will soon be several safe, effective, and reversible contraceptive options available to male patients.
I’m sure the religious ‘wrong’ will take umbrage having men be responsible
#MaleContraception
https://www.washingtonpost.com/science/2023/02/14/male-birth-control-drug-study/?location=alert
Another approach for #malecontraception on the rise. Let's see how long this one lasts..
> A selective inhibitor of the sperm-specific potassium channel #SLO3 impairs human sperm function
KillBait News
KillBait
Kanaillenvogel
BabyYumYum
Bob Jamieson
Howard Smith MD, AM
Mo Edray